Cargando…
Serum Neurofilament Light Chain Measurement in MS: Hurdles to Clinical Translation
Measurement of serum neurofilament light chain concentration (sNfL) promises to become a convenient, cost effective and meaningful adjunct for multiple sclerosis (MS) prognostication as well as monitoring disease activity in response to treatment. Despite the remarkable progress and an ever-increasi...
Autores principales: | Thebault, Simon, Booth, Ronald A., Rush, Carolina A., MacLean, Heather, Freedman, Mark S. |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8027110/ https://www.ncbi.nlm.nih.gov/pubmed/33841093 http://dx.doi.org/10.3389/fnins.2021.654942 |
Ejemplares similares
-
Serum neurofilament light in MS: The first true blood-based
biomarker?
por: Thebault, Simon, et al.
Publicado: (2021) -
Blood Neurofilament Light Chain: The Neurologist’s Troponin?
por: Thebault, Simon, et al.
Publicado: (2020) -
High serum neurofilament light chain normalizes after hematopoietic stem cell transplantation for MS
por: Thebault, Simon, et al.
Publicado: (2019) -
Serum neurofilament light chain predicts long term clinical outcomes in multiple sclerosis
por: Thebault, Simon, et al.
Publicado: (2020) -
Serum neurofilament light chains in MS: Association with the Timed Up and Go
por: Allali, Gilles, et al.
Publicado: (2020)